Compare P&G Hygiene with Similar Stocks
Dashboard
High Management Efficiency with a high ROE of 81.87%
The company is Net-Debt Free
Poor long term growth as Net Sales has grown by an annual rate of 5.52% and Operating profit at 5.34% over the last 5 years
Positive results in Dec 25
With ROE of 92.3, it has a Expensive valuation with a 34.7 Price to Book Value
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Latest dividend: 170 per share ex-dividend date: Feb-05-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Procter & Gamble Hygiene & Health Care Ltd. Upgraded to Hold by MarketsMOJO on Technical Improvements
Procter & Gamble Hygiene & Health Care Ltd. has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced improvement across technical indicators, financial performance, valuation metrics, and quality assessments. Despite ongoing challenges in long-term growth and market returns, the company’s recent quarterly results and technical trend shifts have prompted a reassessment of its outlook within the FMCG sector.
Read full news article
Procter & Gamble Hygiene & Health Care Ltd: Technical Momentum Shifts Amidst Mixed Market Returns
Procter & Gamble Hygiene & Health Care Ltd. has experienced a subtle yet notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest decline in the stock price, the evolving technical indicators suggest a complex interplay of bullish and bearish signals, warranting a closer examination for investors navigating the FMCG sector.
Read full news article
Procter & Gamble Hygiene & Health Care Ltd. is Rated Sell
Procter & Gamble Hygiene & Health Care Ltd. is rated Sell by MarketsMOJO. This rating was last updated on 07 Oct 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
10-Apr-2026 | Source : BSEThe Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026
Intimation Regarding Ease Of Doing Business - Special Window For Transfer And Dematerialization Of Physical Securities
07-Apr-2026 | Source : BSEThe Company has informed the Exchange regarding the update on Special Window for Transfer and Dematerialization of Physical Securities
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
06-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Procter & Gamble Hygiene and Health Care Ltd |
| 2 | CIN NO. | L24239MH1964PLC012971 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary
EmailId: investorpghh.im@pg.com
Designation: Chief Financial Officer
EmailId: investorpghh.im@pg.com
Date: 06/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Corporate Actions 
28 May 2026
Procter & Gamble Hygiene & Health Care Ltd. has declared 1700% dividend, ex-date: 05 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 18 Schemes (8.65%)
Held by 101 FIIs (0.97%)
Procter And Gamble Overseas India B.v. (68.73%)
Sbi Focused Fund (5.06%)
9.8%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 1.10% vs 10.20% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 12.24% vs 17.34% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1.13% vs 1.29% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 25.26% vs -5.46% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






